Abiopharma

🔍 Samaha Eli (Director)

Company: Stagwell Inc (STGW)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 3,180 shares of Class A Common Stock at $6.29 per share (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 145,103.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: see footnote | shares_owned_after: 8,014,322.00 | Footnotes: F2

Footnotes:

• F1: Pursuant to the Issuer's Non-Employee Director Compensation Policy, the reporting person elected to receive payment of quarterly fees for service on the Issuer's Board of Directors in shares of fully vested Class A Common Stock in lieu of a cash payment. The number of shares was calculated based on a $20,000 fee divided by the closing price of the Class A Common stock on the trading day immediately preceding the date of payment.
• F2: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities.